The technology "has broad potential uses in the development of cancer prognostic assays including response predictions to therapeutics as well as research tools and reagents," PrognosDx said in a statement.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.